Efficacy and Safety of Adalimumab and Infliximab for Noninfectious Uveitis.

Felicia Tai Parsa Mehraban Far Petros Pechlivanoglou Lauren C Ramsay Jorge R Georgakopoulos Beate Sander Larissa A Derzko-Dzulynsky Tina Felfeli

Ophthalmology

Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada. Electronic address:

Published: March 2022

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ophtha.2021.09.025	DOI Listing

Publication Analysis

Top Keywords

efficacy safety

safety adalimumab

adalimumab infliximab

infliximab noninfectious

noninfectious uveitis

efficacy

adalimumab

infliximab

noninfectious

uveitis

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!